Genovese Burford & Brothers Wealth & Retirement Plan Management’s iShares Biotechnology ETF IBB Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,291	Closed	-$142K	–	208
2018 Q2	$142K	Buy	1,291 +30	+2%	+$3.21K	0.05%	98
2018 Q1	$135K	Buy	+1,261	New	+$140K	0.05%	97
2017 Q4	–	Sell	-1,164	Closed	-$129K	–	331
2017 Q3	$129K	Hold	1,164	–	–	0.05%	82
2017 Q2	$120K	Hold	1,164	–	–	0.05%	87
2017 Q1	$114K	Sell	1,164 -375	-24%	-$35.9K	0.05%	91
2016 Q4	$137K	Buy	1,539 +3	+0.2%	+$273	0.04%	91
2016 Q3	$148K	Buy	1,536 +321	+26%	+$30.5K	0.06%	75
2016 Q2	$104K	Sell	1,215 -234	-16%	-$21K	0.04%	96
2016 Q1	$126K	Buy	1,449 +234	+19%	+$20.9K	0.06%	79
2015 Q4	$137K	Buy	+1,215	New	+$132K	0.07%	72

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's IBB Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of iShares Biotechnology ETF (IBB) in Q3 2018, closing a stake of 1,291 shares — an estimated $142K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in IBB in Q4 2015 and held it in 10 quarters. The position peaked at $148K in Q3 2016. 631 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining iShares Biotechnology ETF position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 1,291 iShares Biotechnology ETF shares in Q3 2018, an estimated $142K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 10 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's iShares Biotechnology ETF position peaked at $148K in Q3 2016.
631 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.